Winona vs Alloy Women's Health vs Midi Health: Which HRT Telehealth Platform Is Right for You?
Winona vs Alloy Women's Health vs Midi Health: Which HRT Telehealth Platform Is Right for You?
Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.
Pricing and protocol data sourced from each provider's public website, verified April 2026. We have no commercial relationship with any of these providers.
Three platforms dominate the HRT telehealth market for women managing menopause and perimenopause: Winona, Alloy Women's Health, and Midi Health. They serve the same fundamental need — access to hormone replacement therapy without a months-long specialist waitlist — but they differ sharply on medication type, care model, pricing structure, and who they're actually built for.
Alloy Women's Health is the lowest-cost FDA-approved HRT option at approximately $75 per month for the estradiol patch plus progesterone; Winona's compounded BHRT starts at $99 per month; Midi Health charges $250 for an initial visit and $150 for follow-up visits on a self-pay basis, with PPO insurance coverage available.
Which platform wins for your situation — at a glance
| Winona | Alloy Women's Health | Midi Health | |
|---|---|---|---|
| Best for | Compounded BHRT, async convenience, no consult fee | Lowest-cost FDA-approved HRT, menopause specialists | Insured patients, complex cases, broadest clinical scope |
| Monthly cost | $99–$199/month | ~$75/month (quarterly billing) | $250 initial / $150 follow-up (self-pay); copay with insurance |
| Medication type | Compounded BHRT only | FDA-approved primary; compounded available | FDA-approved + compounded |
| Care model | Async (questionnaire + messaging) | Async + video option | Live video consultations |
| Insurance | Cash-pay only | Cash-pay only (HSA/FSA accepted) | PPO plans; no Medicaid, Medicare, Medi-Cal |
| Consult fee | None | $49.95 one-time | Per-visit billing |
| Lab requirement | Optional (~$99 add-on) | Recommended | Typically required |
| Prescriber type | Licensed physicians | NCMP-certified physicians | Menopause-trained OBGYNs and NPs |
| Patches available | No | Yes | Yes |
| Non-hormonal options | None | Fezolinetant, low-dose testosterone | Fezolinetant, SSRIs, bisphosphonates, sleep support |
| GLP-1 prescriptions | No | Yes | No |
| State availability | Verify current list | Verify current list | All 50 states |
Pricing last verified April 2026. We update pricing data monthly.
Why does the choice between Winona, Alloy, and Midi matter beyond price?
The most consequential difference is the question of compounded vs. FDA-approved hormones — and this affects clinical safety evidence, not just preference.
Winona prescribes only compounded bioidentical hormone formulations. Alloy prescribes FDA-approved medications as the default. Midi prescribes both but also defaults to FDA-approved products. The American College of Obstetricians and Gynecologists (ACOG) and The Menopause Society recommend FDA-approved HRT as first-line for most patients because of established safety and efficacy data from large clinical trials. Compounded formulations lack that trial database. They are not unsafe by definition, but the evidence base for their safety at specific custom doses is thinner.
This does not make Winona the wrong choice. Clinical situations where compounding is appropriate are real: documented excipient allergies, formulations not available in commercial products, or women who have tried FDA-approved options and responded better to compounded. But patients without a specific clinical reason to prefer compounding should understand that distinction before enrolling.
For more on the regulatory and clinical context, see our compounded HRT safety guide.
How much does each platform cost?
Alloy is the lowest-cost FDA-approved option. Winona is the lowest-cost compounded option. On a self-pay basis, Midi runs highest — but with PPO insurance, it can be the least expensive of the three.
Pricing last verified April 2026. We update pricing data monthly.
How much does Winona cost?
| Component | Cost |
|---|---|
| Monthly treatment plan | $99–$199/month |
| Consultation fee | None |
| Lab work | Optional; ~$99 add-on |
| Insurance | Not accepted; cash-pay only |
| Included in monthly fee | Physician review, compounded prescription, pharmacy fulfillment, async follow-up |
Winona's monthly fee is all-in. No separate consultation charge, no additional billing for prescription renewals. The $99–$199 range reflects variation in protocol complexity and formulation. Most patients starting on a compounded combination cream or oral estradiol capsule with progesterone fall in the middle of that range. The optional lab panel is the one meaningful add-on, worth the cost for more precise initial dosing.
How much does Alloy Women's Health cost?
| Component | Cost |
|---|---|
| Initial consultation | $49.95 (one-time) |
| Estradiol patch + progesterone | |
| Other treatments | Varies; see myalloy.com |
| Insurance | Not accepted; HSA/FSA accepted |
The $49.95 consultation fee is a real upfront cost that Winona does not charge. But the quarterly billing model brings the effective monthly rate below Winona's monthly equivalent for comparable coverage. Progesterone is included at no extra charge for women with a uterus on the standard patch protocol.
How much does Midi Health cost?
| Component | Cost |
|---|---|
| Initial visit (self-pay) | $250 |
| Follow-up visits (self-pay) | $150 per visit |
| With PPO insurance (in-network) | Standard copay; deductibles apply; vary by plan |
| Medications | Pharmacy benefit (insurance) or retail/GoodRx (self-pay) |
| Medicare, Medicaid, Medi-Cal | Not accepted |
| HSA/FSA | Accepted for self-pay portions |
The insurance math is where Midi's cost profile changes character. A patient with PPO coverage where Midi is in-network might pay standard copays per visit — making it potentially the least expensive option of the three for eligible patients. Self-pay patients face a different calculation: $250 for the initial visit plus $150 per follow-up adds up quickly relative to flat-rate competitors.
The self-pay annual comparison: At two visits per year, Midi self-pay runs ~$550 in visit costs plus pharmacy expenses. Alloy runs approximately $949/year ($49.95 + $75 × 12). Winona runs $1,188–$2,388/year. For uninsured patients, Alloy is the most economical route to FDA-approved HRT.
For detailed cost breakdowns across all platforms, see our online HRT cost guide.
What medications does each platform prescribe?
Medication type determines both the clinical safety evidence base and what conditions each platform can actually treat.
| Medication | Winona | Alloy Women's Health | Midi Health |
|---|---|---|---|
| Estradiol patch — FDA-approved (Vivelle-Dot, Climara, generics) | No | Yes | Yes |
| Estradiol tablet/pill — FDA-approved | No | Yes | Yes |
| Estradiol gel — FDA-approved | No | Limited | Yes |
| Vaginal estrogen — FDA-approved | No | Some formulations | Yes |
| Compounded estradiol/estriol topical cream | Yes — primary | When medically indicated | When medically indicated |
| Compounded oral estrogen capsule | Yes | When medically indicated | When medically indicated |
| Progesterone capsules — FDA-approved (Prometrium or generic) | No | Yes — included for women with a uterus | Yes |
| Compounded progesterone | Yes | When medically indicated | When medically indicated |
| Low-dose testosterone (off-label) | No | Yes | Yes |
| Fezolinetant/Veoza — FDA-approved non-hormonal | No | Yes | Yes |
| SSRIs/SNRIs for hot flashes and mood | No | No | Yes |
| Bisphosphonates for bone density | No | No | Yes |
| Sleep support medications | No | No | Yes |
| GLP-1 medications | No | Yes | No |
Three practical differences stand out:
1. Winona does not prescribe patches. Women who want FDA-approved transdermal estradiol — the delivery route most consistently studied in major clinical trials and recommended by The Menopause Society — cannot get it at Winona. Winona's compounded topical creams are absorbed transdermally, but they are not the same product with the same trial-validated pharmacokinetics as estradiol patches.
2. Alloy and Midi both offer low-dose testosterone for women. Testosterone is widely prescribed off-label for libido, energy, and cognitive function in women, with solid evidence in the menopause literature. Winona does not include it.
3. Midi Health is the only platform with a clinically validated non-hormonal treatment menu. Fezolinetant (Veoza) is FDA-approved specifically for moderate-to-severe hot flashes. SSRIs/SNRIs — particularly paroxetine (Brisdelle, FDA-approved for hot flashes), venlafaxine, and escitalopram — have strong evidence for hot flash reduction and mood support. Women who cannot take hormones due to breast cancer history, clotting disorders, or personal preference have real clinical alternatives at Midi. They have one option (fezolinetant) at Alloy. At Winona, they have none.
What is each platform's prescription process and care model?
How does Winona's prescription process work?
Async from intake through ongoing care. Patients complete a symptom questionnaire — no video call required — and a licensed physician reviews it and prescribes a compounded hormone formulation. The pharmacy ships the medication directly. Follow-up is async messaging with quarterly physician check-ins. There is no required live contact with the prescribing physician at any stage.
The advantage is low friction: no scheduling, fast pathway to treatment, no time zone logistics. The limitation is that dose titration happens entirely through written communication. Patients experiencing partial response need to advocate clearly through the messaging system; there is no real-time clinical exchange to work through ambiguous symptoms.
How does Alloy Women's Health's prescription process work?
Alloy's model is primarily async, but the $49.95 consultation connects patients with an NCMP-credentialed physician for either a video or async intake review — a step above a questionnaire-only process. Prescriptions default to FDA-approved medications. Quarterly 3-month supply shipments reduce refill friction once treatment is established.
Patient reviews document a recurring friction point: dose adjustment requests sometimes encounter slower turnaround. Patients needing a protocol change should flag it early and persist through the messaging system rather than waiting for scheduled refill contact.
How does Midi Health's prescription process work?
Midi requires a live video consultation as the entry point — not a questionnaire reviewed asynchronously, but a real-time clinical conversation. The provider can ask follow-up questions, surface contraindications, review current medications, and establish an individualized treatment plan during the visit.
This is clinically meaningful for patients with complex or ambiguous symptom patterns, or those with concurrent conditions. It is more friction than Winona or Alloy at intake — scheduling a video appointment takes more steps than completing an online form. For straightforward symptom profiles, the async models are adequate. For anything nuanced, the live visit has real clinical value.
Midi is also designed for ongoing care relationships, not one-time prescription access. Follow-up visits are part of the model, not exceptions.
What do the lab requirements tell you about each platform?
Lab policy is a meaningful clinical-quality differentiator that most patients don't ask about until after they've enrolled.
Winona: Lab work is optional. Treatment begins from a symptom questionnaire alone. An optional hormone panel (~$99) is available for patients who want baseline data. Starting without labs is possible but limits dose precision — calibration relies entirely on reported symptoms rather than objective hormone levels.
Alloy Women's Health: Lab work is recommended but not explicitly mandated upfront. NCMP-credentialed physicians with specialty menopause training typically incorporate more thorough clinical intake than general telehealth platforms; current exact requirements should be confirmed during your consultation.
Midi Health: Labs are typically required or strongly recommended before prescribing. The video consultation model means the provider reviews and discusses lab findings with you in real time. This is the most clinically complete intake process of the three.
For patients who want to start quickly without the friction of lab coordination, Winona is the most accessible entry point. For patients who want their protocol calibrated to actual hormone levels, Alloy or Midi is the appropriate choice.
What are the honest criticisms of each platform?
What are Winona's weaknesses?
Winona prescribes only compounded formulations. There are no FDA-approved estradiol patches, pills, or Prometrium capsules available through the platform — meaning patients are excluded from the products that major medical societies recommend as first-line for most women. Lab testing is optional by default, so initial dosing calibration is entirely symptom-based unless the patient proactively adds the panel. Dose titration through async messaging is slower than any video-based model — a real limitation for patients whose initial protocol needs adjustment. Compounding pharmacy supply chains introduce timing unpredictability that standard pharmacy fulfillment does not.
What are Alloy Women's Health's weaknesses?
The $49.95 consultation fee creates a commitment threshold before patients can evaluate whether the platform is right for them. The quarterly billing model reduces the effective monthly cost but requires a larger upfront payment, which some patients find inconvenient relative to monthly plans. Patient reviews consistently flag friction around dose adjustments and subscription management — pausing, canceling, and modifying orders. For women who need non-hormonal alternatives beyond fezolinetant, or who want the live clinical interaction that NCMP credentials alone don't provide, the async model has limits.
What are Midi Health's weaknesses?
Self-pay pricing is substantially higher than Winona or Alloy — $250 for the initial visit is a meaningful upfront cost, and ongoing follow-up adds up. Insurance routing introduces its own friction: prior authorization, variable copay estimates, and in-network confirmation are all required before you know what you'll actually pay. Midi does not prescribe GLP-1 medications, making it the wrong platform for patients seeking combined menopause and weight-management care. Pricing transparency on the public website is limited — most patients need to complete insurance verification or intake to understand their actual cost before booking.
Who should use each platform?
When is Winona the right choice?
Winona is built for patients who specifically want compounded bioidentical hormone formulations, prefer an async care model, pay cash, and want to start without a consultation fee. Women who have previously been on compounded BHRT and know what protocol works for them, or who have a specific clinical reason to prefer compounded formulations, are the clearest fit.
Winona is not appropriate for women who want FDA-approved HRT, need live provider access, require non-hormonal alternatives, or have complex medical histories that need real-time clinical evaluation.
Full independent review: Winona HRT review
When is Alloy Women's Health the right choice?
Alloy is the strongest cash-pay option for women who want FDA-approved HRT with specialty-credentialed physicians at the lowest available price point. The NCMP credential on every prescribing physician is a genuine clinical quality signal, not a marketing claim. At approximately $75/month for estradiol patch plus progesterone, Alloy undercuts Winona's monthly pricing for a protocol with stronger trial-backed safety data.
Alloy is a good fit for women who want FDA-approved medications, are comfortable with predominantly async care, pay cash (or use HSA/FSA), don't need live video visits, and don't need insurance billing.
Full independent review: Alloy Women's Health review
When is Midi Health the right choice?
Midi's strongest case is insurance coverage. For PPO-insured patients where Midi is in-network, visit costs drop to standard copays — making it likely the lowest total-cost option for eligible patients. The clinical scope is also the broadest of the three platforms: SSRIs, bisphosphonates, sleep medications, and fezolinetant alongside HRT means patients with complex or multi-symptom presentations have more options managed by one provider who knows their full picture.
Midi is the right choice for insured patients, for women with complex or multiple concurrent symptoms, for patients who cannot or choose not to take hormones and need real non-hormonal clinical alternatives, and for anyone who wants a live video relationship with their prescribing provider.
Full independent review: Midi Health review
What is the bottom-line recommendation?
Three questions cut through this comparison quickly:
1. Do you have PPO insurance? Check Midi Health's in-network status first. With coverage, it is likely the most clinically comprehensive and potentially lowest out-of-pocket option.
2. Are you cash-pay and want FDA-approved HRT? Alloy Women's Health at ~$75/month with NCMP-certified physicians is the best combination of price, clinical credentials, and medication quality.
3. Are you cash-pay and specifically want compounded BHRT? Winona at $99–$199/month is the most accessible async option with no consultation fee to start.
None of the three platforms are appropriate substitutes for specialist evaluation when there is a personal history of breast cancer, clotting disorders, or significant cardiovascular disease. All three are suited to otherwise healthy women with straightforward perimenopause or menopause symptom profiles.
For the broader landscape of HRT telehealth options, see our best online HRT guide.
How We Evaluated
This comparison was built from independent research on each provider's public website, current pricing pages, and patient reviews (Trustpilot, Google). We reviewed each provider's individual patient intake process, prescribing scope, and published clinical protocols. All three providers have independent full reviews on Telehealth Ally — see Winona review, Alloy Women's Health review, and Midi Health review. No provider influenced this comparison. Revenue does not influence rankings or recommendations. Our editorial independence policy is at /about.
Frequently Asked Questions
Which is better, Winona or Alloy Women's Health?
For most cash-pay patients, Alloy Women's Health is the stronger clinical choice: it prescribes FDA-approved HRT at a lower effective monthly cost (~$75/month vs Winona's $99–$199/month), and its physicians hold the NCMP credential from The Menopause Society. Winona is the better fit for patients who specifically want compounded bioidentical hormone formulations, want no upfront consultation fee, or prefer monthly billing flexibility. The core clinical difference is that Alloy's medications have large-trial safety data; Winona's compounded formulations do not.
Which is better, Alloy Women's Health or Midi Health for menopause?
For insured patients, Midi Health's insurance coverage typically makes it the lower out-of-pocket option, and its clinical scope — SSRIs, fezolinetant, bisphosphonates alongside HRT — is the broadest of the three platforms. For cash-pay patients who want a predictable monthly rate with menopause-specialist physicians, Alloy Women's Health at ~$75/month is simpler to budget and delivers strong clinical credentials.
How much does Midi Health cost without insurance?
Midi Health charges $250 for the initial visit and $150 for follow-up visits on a self-pay basis. Medications are filled at retail pharmacy rates or GoodRx pricing. There is no subscription fee. Midi does not accept Medicaid, Medi-Cal, or original Medicare — only PPO insurance and some Medicare Advantage plans. Confirm in-network status before booking.
Does Winona prescribe estradiol patches?
No. Winona prescribes compounded bioidentical hormone formulations only — oral capsules, topical creams, and vaginal suppositories prepared by compounding pharmacies. It does not prescribe FDA-approved finished HRT products, including transdermal estradiol patches (Vivelle-Dot, Climara, and generics). For estradiol patches, Alloy Women's Health and Midi Health are the appropriate telehealth options.
What is the cheapest HRT telehealth platform?
Alloy Women's Health offers the lowest effective monthly cost for FDA-approved HRT at approximately $75 per month for the estradiol patch plus progesterone protocol, billed quarterly with progesterone included. Winona's compounded BHRT starts at $99/month. Midi Health is the least expensive option for insured patients with PPO coverage, where visit costs may be reduced to standard copays depending on the plan.
Does Alloy Women's Health take insurance?
No. Alloy Women's Health is cash-pay only. It accepts HSA and FSA cards. For patients who need insurance-billed menopause telehealth, Midi Health is the only major platform with broad PPO network coverage.
Is Alloy Women's Health better than Winona for perimenopause?
Alloy Women's Health is generally the stronger clinical choice for perimenopause. It prescribes FDA-approved HRT, offers non-hormonal options (fezolinetant, low-dose testosterone), and all prescribing physicians hold the NCMP credential from The Menopause Society. Perimenopause — with its variable, fluctuating symptom pattern — often benefits from a practitioner with specialty menopause training. Winona's strength is lower-friction async access to compounded BHRT; its limitations for perimenopause are the absence of FDA-approved medication options and non-hormonal alternatives.
What is the difference between compounded and FDA-approved HRT?
FDA-approved HRT — estradiol patches, pills, vaginal preparations, and progesterone capsules like Prometrium — has been evaluated in large clinical trials for safety, efficacy, and dosing consistency before regulatory approval. Compounded BHRT, prescribed by Winona and available at Alloy and Midi when clinically indicated, is prepared by a compounding pharmacy for an individual patient and is not FDA-approved as a finished product. It lacks the large-trial safety data that applies to FDA-approved versions. Major medical societies recommend FDA-approved products as the first-line choice for most patients. Compounding is appropriate when there is a specific clinical reason — excipient allergies, non-standard dosing needs, or formulations not available commercially. For a full clinical explainer, see our compounded HRT safety guide.
Pricing and protocol data sourced from Winona, Alloy Women's Health, and Midi Health's public websites, verified April 2026. We have no commercial relationship with these providers.
Where to Get These Medications
Compare providers offering GLP-1 medications.